What Is the Best Medication for Nerve Pain?

There is no single best medication for nerve pain. The right choice depends on the type of nerve pain you have, your other health conditions, and how your body responds to treatment. That said, clinical guidelines consistently recommend three classes of medication as first-line options: gabapentinoids, SNRIs (a type of antidepressant), and tricyclic antidepressants. Most people will start with one of these, and finding the right fit often takes some trial and adjustment.

Why Nerve Pain Needs Its Own Category of Treatment

Standard painkillers like ibuprofen and acetaminophen don’t work well for nerve pain. That’s because nerve pain (also called neuropathic pain) comes from damaged or misfiring nerves sending faulty signals to the brain, not from inflammation or tissue injury. The medications that help are ones that calm overactive nerve signals or change how the brain processes pain. This is why the drugs used for nerve pain overlap with medications originally designed for seizures or depression.

Gabapentinoids: Gabapentin and Pregabalin

Gabapentin and pregabalin are among the most widely prescribed medications for nerve pain. They work by reducing the release of chemical messengers that amplify pain signals between nerves. A Cochrane review found that both medications perform similarly: roughly 1 in 7 people who take either drug will experience at least a 50% reduction in pain intensity. That may sound modest, but for chronic nerve pain, meaningful relief in even a portion of patients is considered a real clinical win.

The most common side effects are drowsiness, dizziness, “brain fog” (difficulty concentrating and short-term memory issues), blurred vision, dry mouth, swelling in the hands or feet, and weight gain. Many patients in FDA surveys described feeling mentally dulled, which can be a dealbreaker for people who need to stay sharp during the day. These effects are often worst in the first few weeks and may ease as your body adjusts. Starting at a low dose and increasing gradually helps.

For adults over 65, gabapentinoids carry additional warnings. The American Geriatrics Society flags both gabapentin and pregabalin as potentially harmful in older adults, particularly when combined with opioids, because of increased risks of sedation, falls, and breathing problems.

SNRIs: Duloxetine and Venlafaxine

SNRIs boost levels of two brain chemicals, serotonin and norepinephrine, that play a role in dampening pain signals as they travel through the spinal cord. Of the two main SNRIs used for nerve pain, duloxetine has far stronger evidence behind it. It carries FDA approval for diabetic peripheral neuropathy, fibromyalgia, and chronic musculoskeletal pain. Venlafaxine is sometimes used off-label for nerve pain but has no FDA approval for any pain condition.

Duloxetine is often a good starting point for people who also have depression or anxiety, since it treats both conditions simultaneously. Common side effects include nausea, dry mouth, fatigue, and constipation. Most people tolerate it reasonably well, and the side effect profile is generally milder than tricyclic antidepressants.

Tricyclic Antidepressants

Tricyclic antidepressants are one of the oldest treatments for nerve pain and remain a first-line recommendation despite being developed decades ago. Nortriptyline and amitriptyline are the two most commonly prescribed. For nerve pain, doses are much lower than those used for depression. Nortriptyline, for example, typically starts at just 10 mg once daily and can be increased gradually up to 75 mg under specialist supervision.

The trade-off with tricyclics is their side effect burden. They have strong anticholinergic effects, meaning they can cause dry mouth, constipation, blurred vision, difficulty urinating, and drowsiness. In older adults, these effects are more pronounced and more dangerous. Confusion, loss of balance, lightheadedness, and changes in heart rhythm make tricyclics a riskier choice for anyone over 65. For younger patients who tolerate them, though, they can be highly effective and inexpensive.

Topical Options for Localized Pain

When nerve pain is confined to a specific area, such as a patch of skin affected by shingles or a painful spot on the feet from diabetic neuropathy, topical treatments can deliver relief without the whole-body side effects of oral medications. Two main options exist: lidocaine patches and capsaicin cream.

Lidocaine patches numb the area by blocking nerve signals locally. They’re applied directly over the painful region and are particularly popular for post-shingles pain. Capsaicin, the compound that makes chili peppers hot, works differently. It initially activates pain-sensing nerves, then gradually desensitizes them over time. Over-the-counter capsaicin cream is applied three to four times a day. Higher-concentration capsaicin patches, available through a clinician, are left on for 30 to 60 minutes depending on the condition being treated and can provide weeks of relief from a single application.

Topical treatments are sometimes used alone for mild cases or combined with an oral medication when pain is more severe. Their biggest advantage is that they cause minimal systemic side effects, making them a practical addition for people who are sensitive to oral medications.

Trigeminal Neuralgia Is Treated Differently

One important exception to the standard first-line recommendations is trigeminal neuralgia, a condition that causes intense, stabbing pain in the face. The go-to medication here is carbamazepine, an anti-seizure drug that is uniquely effective for this type of nerve pain. It typically starts at 200 mg per day and can be increased as needed, though doses rarely exceed 1,200 mg daily. If you’re dealing with facial nerve pain specifically, this is the medication your doctor will likely try first.

Second-Line and Combination Approaches

When first-line medications don’t provide enough relief on their own, the next step is usually combining two first-line drugs from different classes (for example, pairing a gabapentinoid with an SNRI) or moving to second-line options. Tramadol, a mild opioid-like pain reliever that also affects serotonin and norepinephrine, falls into this category. It has moderate evidence for both central and peripheral nerve pain, but it comes with risks including constipation, nausea, and the potential for dependence.

Stronger opioids are reserved as a third-line option and are used cautiously. Tolerance develops over time, meaning you need higher doses for the same effect, and the risk of dependence and overdose is significant. Guidelines give strong opioids only a weak recommendation for nerve pain, and they’re generally considered appropriate only when other treatments have failed.

How to Find the Right Fit

Finding effective nerve pain treatment is rarely a straight line. Most people try at least two or three medications before landing on something that works well enough with tolerable side effects. A few practical realities shape the process:

  • Start low, go slow. Nearly all nerve pain medications are introduced at a low dose and increased over weeks. This minimizes side effects and helps identify the lowest effective dose.
  • Give it time. Most medications need four to eight weeks at an adequate dose before you can fairly judge whether they’re helping.
  • Complete relief is uncommon. A realistic goal for most people is a 30% to 50% reduction in pain intensity, not total elimination. Improvement in sleep and daily function matters as much as the pain score itself.
  • Your age and health history matter. Older adults generally do better with duloxetine or topical treatments than with tricyclics or high-dose gabapentinoids. People with kidney problems may need dose adjustments for gabapentin. Existing depression or anxiety can make an SNRI a logical dual-purpose choice.

The “best” medication is ultimately the one that gives you meaningful relief without side effects that undermine your quality of life. That answer is personal, and it’s found through a structured process of trying, adjusting, and combining treatments rather than picking a single winner off a list.